ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 109 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $1,348,000 | -54.6% | 26,500 | -64.7% | 0.16% | -10.1% |
| Q3 2014 | $2,972,000 | -34.4% | 75,110 | -28.6% | 0.18% | -11.4% |
| Q2 2014 | $4,529,000 | -5.8% | 105,150 | -12.6% | 0.20% | +57.0% |
| Q1 2014 | $4,810,000 | +84.5% | 120,300 | +25.9% | 0.13% | +172.3% |
| Q4 2013 | $2,607,000 | +9.8% | 95,530 | -7.8% | 0.05% | +20.5% |
| Q3 2013 | $2,374,000 | +50.3% | 103,560 | +16.1% | 0.04% | +85.7% |
| Q2 2013 | $1,580,000 | – | 89,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |